Status:
COMPLETED
Collaborative Research on HFR High Flux
Lead Sponsor:
Azienda Sanitaria Locale di Cagliari
Collaborating Sponsors:
Bellco s.r.l.
Istituto Superiore di Sanità
Conditions:
Inflammation
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the serum concentrations of antoxidant vitamines A, C, E, inflammatory cytokines and middle-large toxins in patients treated with online hemodiafiltration, sta...
Detailed Description
Today, as the research work of EUTOX group highlights, large cytokines and protein-bound solutes are gaining a relevant attention because of their emerging role as mortality predictors. Online hemodi...
Eligibility Criteria
Inclusion
- dialysis vintage \> 6 months
- well functioning vascular access (QB \> 300 mL/min)
- informed consent given
Exclusion
- polycystic kidney disease (PKD)
- significant acute or chronic inflammatory comorbidities
- non-renal related anemia
- blood transfusions in the last 2 months before enrollment
- alcohol or drugs abuse
- malignant neoplasm
- hemoglobinopathy or myelopathy
- pregnancy
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01492491
Start Date
September 1 2011
End Date
March 1 2013
Last Update
June 14 2016
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Territorial dialysis service, Regional Health system nephrology and dialysis department
Cagliari, Italy, 09045
2
Nephrology and dialysis, SS. Trinità Hospital
Cagliari, Italy, 09132
3
Nephrology and dialysis, Civil Hospital
La Maddalena, Italy, 07024
4
Nephrology and dialysis, Civil Hospital
Lanusei, Italy, 08045